Can CBD Help Treat or Prevent Diabetes?
Could CBD be used to treat, or even prevent diabetes? There is evidence that CBD possesses medicinal characteristics which could be of benefit in both the treatment and prevention of diabetes, a disease which affects more than 29 million people in the United States.
Diabetes is the term for a group of related metabolic disorders characterized by prolonged high blood sugar levels for which there are no cure. One in every 10 adults who are 20 years or older has some form of diabetes. It can be a debilitating and life-threatening disease. In fact, diabetes causes up to five million deaths per year.
CBD and Diabetes
Diabetics have multiple challenges to overcome. Aside from dealing with high blood sugar, diabetics also have to contend with something called neuropathic pain. Between having to deal with constant blood sugar monitoring and insulin injections, their chronic pain can make diabetics depressed and anxious. Diabetes is also a major cause of blindness which results from degeneration of tiny blood vessels in the eyes.
CBD seems to have some positive effects on all of these conditions. It has been shown to help control blood sugar, it has neuroprotective properties, and it acts as an anti-inflammatory and an antioxidant. There is also ample evidence that cannabis increases nerve growth, which might help to prevent the nerve damage which causes neuropathic pain.
There’s a mountain of anecdotal reports that cannabis improves mood and reduces anxiety and plenty of research to back that up as well. Several studies have also shown that CBD helps with weight loss, which can reduce many symptoms of diabetes.
For much more information, check out these studies on CBD and diabetes, from ProjectCBD.org:
- The impact of marijuana use on glucose, insulin, and insulin resistance among US adults
- CBD attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy
- CBD lowers incidence of diabetes in non-obese diabetic mice
- Neuroprotective and blood-retinal barrier-preserving effects of CBD in experimental diabetes
- Cannabidiol arrests onset of autoimmune diabetes in NOD mice
- Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation
- Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes
- The endocannabinoid system in obesity and type 2 diabetes
- Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes
- The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications
- Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain
- Biochemical and immunohistochemical changes in delta-9-tetrahydrocannabinol-treated type 2 diabetic rats
- Efficacy and Safety of CBD and THC-V on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes